What is Janssen carepath?
Through Janssen CarePath, we offer resources and support for U.S. patients to start and stay on prescribed Janssen therapy. Our Janssen CarePath coordinators can assist patients with answering questions about insurance coverage for our products and help identify options that may help make Janssen products more affordable, if needed.
Does Janssen provide reimbursement for prescription drugs?
This information is provided for informational purposes only and represents no statement, promise, or guarantee by Janssen concerning levels of reimbursement, payment, or charge. The Partnership for Prescription Assistance (PPA) helps qualifying U.S. patients without prescription drug coverage get the medicines they need for free or nearly free.
What is Janssen doing to transform healthcare?
Backed by the size and reach of Johnson & Johnson, we are transforming lives and reinventing healthcare as we tackle society's most pressing health challenges. You can count on us to never stop working toward a future where disease is a thing of the past. Find the latest Janssen news on our social media feeds.
What is the Johnson&Johnson Patient Assistance Foundation?
Johnson & Johnson Patient Assistance Foundation, Inc. The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a nonprofit organization that assists U.S. patients without adequate financial resources and prescription coverage in obtaining free products donated by the operating companies of Johnson & Johnson.
See more
Does Janssen Pharmaceuticals have a patient assistance program?
Janssen is committed to helping patients obtain appropriate access to our medicines. We partner with private and public payers and healthcare systems to support availability of our products and we offer and support a variety of programs and services to assist with access to and appropriate use of new treatment options.
What can I use my Janssen CarePath card for?
The Janssen CarePath Savings Program is designed to help lower eligible patients' out-of-pocket medication costs for their Janssen medication. Eligible patients using commercial or private insurance to pay for their Janssen medication will receive savings off their deductible, co-pay, and co-insurance medication costs.
How do I contact Janssen?
Note: If you have questions regarding our products, need to report an adverse event, or have a product quality complaint, please contact Janssen Medical Information at 800-JANSSEN (800-526-7736), Monday through Friday, 9:00 AM - 8:00 PM ET.
How do people afford Remicade?
Eligible patients using commercial or private insurance can save on out-of-pocket medication costs for REMICADE®. Depending on the health insurance plan, savings may apply toward co-pay, co-insurance, or deductible. Eligible patients pay $5 for each infusion, with a $20,000 maximum program benefit per calendar year.
Does Janssen CarePath work with Medicare?
If you use commercial or private health insurance, Janssen CarePath Savings Program may help you save on your out-of-pocket costs. Patients using Medicare, Medicaid, or any other federally funded programs to pay for their Janssen medication are not eligible to participate.
Does Janssen CarePath expire?
You must meet the program requirements every time you use the card. Program terms will expire at the end of each calendar year. The program may change or end without notice, including in specific states.
Is Janssen Pharmaceuticals part of Johnson and Johnson?
Janssen Pharmaceutica was acquired by Johnson & Johnson, bringing to the company Janssen's strong capabilities in the growing field of pharmaceutical medicines. For Dr Paul Janssen, the global reach of Johnson & Johnson would enable him and his colleagues to help more patients.
Where is Janssen Pharmaceuticals located?
Headquartered in Titusville, New Jersey, Janssen is named after Dr. Paul Janssen, a leading pharmaceutical researcher, pharmacologist and general practitioner.
Who owns Janssen?
Johnson & JohnsonJanssen Pharmaceuticals / Parent organizationJohnson & Johnson acquired Janssen Pharmaceutica, a Belgian research and drug company founded by Dr. Paul Janssen—one of the century's greatest innovators. Over the course of Dr. Janssen's prolific career, he held more than 100 patents and authored or co-authored more than 850 scientific publications.
How much does one infusion of Remicade cost?
A single dose of Remicade can cost from $1,300 to $2,500. The first step is determining insurance coverage for the infusion. Medicare does cover Remicade infusions.
How long do you stay on Remicade?
There is no limit on the amount of time a patient can take Remicade (infliximab). The drug has been available since 1998, and many patients have been successfully treated and have been on Remicade for more than six years.
How much is Remicade out-of-pocket?
How much does Remicade cost without insurance? Remicade could cost around $4,000 to $7,000 or more per dose. That can add up to about $46,000 if Remicade is given every eight weeks for a year.
Does Janssen CarePath count towards deductible?
Janssen CarePath Savings Program can help eligible commercially-insured patients save on out-of-pocket costs for their Janssen medication. Depending on your health insurance plan, savings may apply toward co-pay, co-insurance, or deductible.
What is CarePath?
A leader in virtual care, Carepath is an innovative healthcare navigation service that provides comprehensive and personalized support to members and their families in the event of illness or other health crises.
What is Janssen link?
Janssen Link for PONVORY® enables eligible patients to receive PONVORY® at no cost until they receive coverage or for up to 24 months from program enrollment, whichever comes first, if these requirements are met.
What is Janssen committed to?
Janssen is committed to helping patients obtain appropriate access to our medicines. We partner with private and public payers and healthcare systems to support availability of our products and we offer and support a variety of programs and services to assist with access to and appropriate use of new treatment options.
What is JJPAF in medicine?
JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.
What is JJPAF?
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a nonprofit organization that assists U.S. patients without adequate financial resources and prescription coverage in obtaining free products donated by the operating companies of Johnson & Johnson. JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.
What is Janssen Pharmaceuticals?from jnj.com
Janssen Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is based in Titusville, New Jersey, and is the only large pharmaceutical company in the United States dedicated solely to mental health. Janssen currently markets prescription medications for the treatment of schizophrenia, Bipolar 1 Disorder, and schizoaffective disorder.
Is Ortho McNeil recalled?from jnj.com
Ortho-McNeil-Janssen Pharmaceuticals, Inc. has initiated these recalls in the U.S. and Puerto Rico at the wholesale and retail (pharmacy) level and is communicating this information to these customers. The company does not anticipate a product shortage resulting from this action.
Who owns Janssen Pharmaceuticals?from en.wikipedia.org
Janssen Pharmaceuticals is a pharmaceutical company headquartered in Beerse, Belgium, and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen .
What is Janssen's core activity?from en.wikipedia.org
From the beginning, Janssen emphasized as its core activity research for the development of new drugs. The research department which was established in Beerse in 1957, developed into a large research campus. In 1987, the Janssen Research Foundation (JRF) was founded which performs research into new drugs at Beerse and in other laboratories around the globe. Janssen became the Flemish company with the largest budget for research and development. Beside the headquarters in Beerse with its research departments, pharmaceutical production and the administrative departments, Janssen Pharmaceutica in Belgium still has offices in Berchem ( Janssen-Cilag ), a chemical factory in Geel, and Janssen Biotech in Olen .
How many Janssen drugs are on the WHO model list?from en.wikipedia.org
Eight original Janssen drugs have been included on the WHO Model List of Essential Medicines :
How many NCEs does Janssen have?from en.wikipedia.org
Janssen Pharmaceuticals has developed and brought to the market about 70 new active substances ( NCE ), of which the most well-known are (name may differ):
What are the contraindications of Janssen?from cdc.gov
Contraindications: Severe allergic reaction (e.g., anaphylaxis) to a previous dose or component of Janssen COVID-19 Vaccine. Immediate allergic reaction* of any severity to a previous dose or known (diagnosed) allergy to a component of the vaccine.
When did Paul Janssen start his own company?from en.wikipedia.org
Paul Janssen founded his own research laboratory in 1953 on the third floor of the building in the Statiestraat, still within the Richter-Eurpharma company of his father. In 1955, he and his team developed their first drug, Neomeritine ( ambucetamide ), an antispasmodic found to be particularly effective for the relief of menstrual pain. On 5 April 1956, the name of the company was changed to NV Laboratoria Pharmaceutica C. Janssen (named after Constant Janssen). On 27 April 1957, the company opened a new research facility in Beerse, but the move to Beerse would not be completed until 1971–1972. On 2 May 1958, the research department in Beerse became a separate legal entity, the N.V. Research Laboratorium C. Janssen .
How much did Omnicare settle for?from en.wikipedia.org
The lawsuit resulted in a 2012 provisional settlement totaling $2.3 billion, with Omnicare having already settled for around $100 million. Four states were awarded damages: Louisiana ($258 million in 2010), South Carolina ($327 million in 2011), Texas ($158 million in 2012), and Arkansas ($1.2 billion in 2012).
Eligibility
Most programs have income, age, and other eligibility requirements. At this current time we don´t have the eligibility information for Janssen Ortho Patient Assistance Foundation's program.
Other Tips
If you have any questions please call the Janssen Ortho Patient Assistance Foundation program directly.
What is Janssen committed to?from janssen.com
Janssen is committed to helping patients obtain appropriate access to our medicines. We partner with private and public payers and healthcare systems to support availability of our products and we offer and support a variety of programs and services to assist with access to and appropriate use of new treatment options.
How many patients did Johnson and Johnson help in 2019?from janssen.com
In 2019, the Janssen Pharmaceutical Companies of Johnson & Johnson helped approximately 1.3 million patients through the Janssen CarePath program. This includes approximately 540,000 commercially insured patients who reduced their out-of-pocket expenditures through the Janssen CarePath Savings Program.
What is JJPAF in medicine?from janssen.com
JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.
